SWOG clinical trial number
CTSU/A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer (BWEL)
Closed
Phase
Abbreviated Title
Breast Cancer WEight Loss Study (BWEL Study)
Status Notes
Permanently closed to accrual, effective 02/15/2021.
This study is active in SWOG effective 4/1/17.
This study is active in SWOG effective 4/1/17.
Activated
08/26/2016
Closed
02/15/2021
Research committees
Breast Cancer
Symptom Control and Quality of Life
Eligibility Criteria Expand/Collapse
Eligibility criteria are accessible from the protocol abstract page on the CTSU website (http://www.ctsu.org).
Publication Information Expand/Collapse
2022
2017
Other Clinical Trials
SWOG Clinical Trial Number
S2205
ICE COMPRESS: Randomized Trial of Limb Cryocompression versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuroropathy
Research Committee(s)
Symptom Control and Quality of Life
Activated
03/16/2023
Accrual
32%
Open
Phase
SWOG Clinical Trial Number
S2010
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence with Endocrine Therapy in Young Women With Stage I-III Breast Cancer (ASPEN)
Research Committee(s)
Symptom Control and Quality of Life
Activated
01/17/2023
Accrual
91%
Open
Phase
SWOG Clinical Trial Number
EAQ202
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Research Committee(s)
Symptom Control and Quality of Life
Activated
10/28/2021
Open
Phase